Rare disease drug developers face three major market access challenges in the EU market today. Parexel Pricing and Market Access expert, Sangeeta Budhia, shares what they need to know to succeed.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
